Showing results (1281-1290 of 1,490) with videos related to

Sort By:
Pageof 149
The Lancet. Oncology|September 5, 2015
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE studyChiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 19, 2025
Atypical depression is associated with a distinct clinical, neurobiological, treatment response and polygenic risk profileMirim Shin, Jacob J Crouse, Tian Lin, et al.
Journal for Immunotherapy of Cancer|May 13, 2026
Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenicClaudia Tonini, Andrea Bianchi, Mauro Esposito, et al.
Veterinary Parasitology|February 2, 2016
An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasisMariana Costa Duarte, Letícia Martins dos Reis Lage, Daniela Pagliara Lage, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]|November 5, 2024
Highly resistant Salmonella Heidelberg circulating in broiler farms in southern BrazilBianca Fagundes Saggin, Karen Apellanis Borges, Thales Quedi Furian, et al.
Cancers|June 28, 2023
The Impact of NUTRItional Status at First Medical Oncology Visit on Clinical Outcomes: The NUTRIONCO StudyMaurizio Muscaritoli, Alessandra Modena, Matteo Valerio, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|March 18, 2006
[5alpha-reductase type 2 deficiency: experiences from Campinas (SP) and Salvador (BA)]Christine Hackel, Luiz Eduardo C de Oliveira, Maria Betania Toralles, et al.
American Journal of Medical Genetics. Part A|November 15, 2015
Craniosynostosis in 10q26 deletion patients: A consequence of brain underdevelopment or altered suture biology?Ágatha Cristhina Faria, Eliete Rabbi-Bortolini, Maria R G O Rebouças, et al.
The Pharmacogenomics Journal|December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancerF Graziano, A Ruzzo, E Canestrari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancerFrancesco Graziano, Annamaria Ruzzo, Fotios Loupakis, et al.
Pageof 149